← Evidence map

ArticleCells2022

Effects of the Mutant TP53 Reactivator APR-246 on Therapeutic Sensitivity of Pancreatic Cancer Cells in the Presence and Absence of WT-TP53.

Stephen L Abrams et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

8 papers cite it

2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35269416